公司資料
Calliditas Therapeutics AB 股價、新聞與催化劑
- 股票代碼:
- CALT
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Sweden
股價為何變動
Current closing-price context is not available for CALT.
公司概覽
業務概覽
Calliditas Therapeutics was a rare-disease and kidney-disease company focused on IgA nephropathy and related conditions before becoming a historical ticker. Its business reflected the value of specialty renal therapeutics in orphan disease.
所在地與產業分類
Calliditas was headquartered in Sweden and listed on NASDAQ. It sat in rare-disease biotechnology.
商業模式特徵
The company depended on clinical success, label expansion, and commercial execution in a focused nephrology market. Investors watched regulatory progress and launch performance.
生技產業定位
Calliditas belongs to the historical rare-disease kidney bucket. It was a premium specialty biotech story before its strategic transition and legacy status.
未來催化劑
- Calliditas is now largely a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like a live growth name.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。